our board and management are committed to delivering...

2
8 MEDICLINIC INTEGRATED ANNUAL REPORT 2012 BOARD OF DIRECTORS OUR BOARD AND MANAGEMENT ARE COMMITTED TO DELIVERING SHAREHOLDER VALUE EXECUTIVE DIRECTORS 1. E de la H (Edwin) Hertzog (62) Chairman M.B.Ch.B., M.Med., F.F.A. (SA) Appointed in 1983 as Managing Director, in 1990 as executive Vice-chairman and in 1992 as executive* Chairman of the Company. Other directorships include Distell, Remgro and Total (SA). 2. DP (Danie) Meintjes (56) Chief Executive Officer B.PI. (Hons) Joined the Group in 1985 and appointed in 1996 as a director of the Company. Seconded to Dubai in 2006 and appointed as the Chief Executive Officer of Emirates Healthcare in 2007. Appointed as the Company’s Chief Executive Officer since April 2010. 3. CI (Craig) Tingle (53) Chief Financial Officer B.Sc. (For), B.Compt. (Hons), CA(SA) Appointed in 1992 as the Financial Director of the Company. After his resignation as the Financial Director in 1999, he stayed on as a non-executive director until 2005 when he was appointed as the Chief Financial Officer of the Company’s operations in Dubai. Appointed as the Company’s Chief Financial Officer since September 2010. 4. CA (Ronnie) van der Merwe (49) Chief Clinical Officer M.B.Ch.B., D.A. (SA), F.C.A. (SA) Joined the Group in 1999 as head of the Clinical Information Department. Currently the Chief Clinical Officer of the Company. Appointed as an executive director of the Company in July 2010. 5. KHS (Koert) Pretorius (49) Chief Executive Officer: Mediclinic Southern Africa B.Compt., MBL Joined the Group in 1998 and appointed as a director of the Company in 2006. Appointed as the Chief Executive Officer of Mediclinic Southern Africa in 2008. 6. TO (Ole) Wiesinger (49) Chief Executive Officer: Mediclinic Switzerland (Hirslanden) Ph.D., Postgraduate Studies in Health Economics Joined the Hirslanden group in 2004. Appointed as the Chief Executive Officer of Mediclinic Switzerland and a director of the Company in 2008. INDEPENDENT NON-EXECUTIVE DIRECTORS 7. DK (Desmond) Smith (65) Lead Independent Director B.Sc., FASSA Chairman of the Reinsurance Group of America (RGA) and Sanlam. Appointed in 2008 as a director of the Company. Also appointed as the Lead Independent Director of the Company in 2010. 8. RE (Robert) Leu (65) Master in Economics, Ph.D., Professor in Economics Executive director of the Department of Economics at the University of Berne in Switzerland. Also serves on the board of Mediclinic Switzerland. Appointed as an independent non-executive director of the Company in July 2010. 9. ZP (Zodwa) Manase (51) B.Compt. (Hons), H.Dip. (Tax), CA(SA) Chief Executive Officer of the audit firm, Manase & Associates. Appointed as a director of the Company in 2008. Other directorships include Total (SA), State Information Technology Agency and MTN Zakhele. 10. AA (Anton) Raath (56) B.Comm., CA(SA) Chief Executive Officer of Glacier, a subsidiary of Sanlam. Appointed as a director of the Company in 1996. 11. WL (Wynand) van der Merwe (60) M.B.Ch.B., M.Med., F.F.A. (SA), MD Dean of the Faculty Health Sciences of Stellenbosch University. Appointed as a director of the Company in 2001. NON-EXECUTIVE DIRECTORS** 12. JC (Joe) Cohen (45) B.Sc. in Economics A managing partner of Trilantic Capital Partners. Appointed as a director of the Company in 2008. 13. JJ (Jannie) Durand (45) B.Acc. (Hons), M.Phil. (Management Studies), CA(SA) Chief Executive Officer of Remgro. Appointed as a director of the Company in June 2012. Other directorships include Capevin Holdings, Discovery Holdings, Grindrod, Invenfin, Kagiso Tiso Holdings, Rainbow Chicken and Sabido Investments. 14. MK (Kabs) Makaba (59) M.B.Ch.B., Intermediate Diploma in Personnel Management and Training, Certificate in Small Business Management Chief Executive Officer of Faranani Health Solutions and director of Phodiso Holdings and Ubelele Holdings. Appointed as a director of the Company in 2008. 15. MA (Mamphela) Ramphele (64) M.B.Ch.B., Diploma in Tropical Health and Hygiene, B.Comm., Diploma in Public Health, Ph.D. Chairperson of Gold Fields. Appointed as a director of the Company in 2005. Other directorships include Remgro and Anglo American. 16. CM (Chris) van den Heever (47) B.Eng. (Chem), MBA An investment manager at Remgro (and previously at VenFin). Appointed as a director of the Company in 2010. Other directorships include One Digital Media, Tracker, Tsb Sugar and Wispeco. * Please refer to the explanation in respect of the classification of Dr Hertzog as executive chairman on page 76 of this annual report. ** Please refer to the explanation why these directors are not regarded as independent on page 77 of the Corporate Governance Report.

Upload: others

Post on 13-Jun-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: our boarD aND MaNagEMENt arE CoMMIttED to DELIvErINg ...annualreport2012.mediclinic.com/downloads/Overview... · B.Compt., MBL Joined the group in 1998 and appointed as a director

8 MEDICLINIC INTEGRATED ANNUAL REPORT 2012

boarD of DIrECtors

our boarD aND MaNagEMENt arE CoMMIttED to DELIvErINg sharEhoLDEr vaLuE

ExECutIvE DIrECtors 1. E de la h (Edwin) hertzog (62)ChairmanM.B.Ch.B., M.Med., F.F.A. (SA) appointed in 1983 as Managing director, in 1990 as executive Vice-chairman and in 1992 as executive* Chairman of the Company. other directorships include distell, remgro and total (Sa).

2. DP (Danie) Meintjes (56)Chief Executive officer B.PI. (Hons) Joined the group in 1985 and appointed in 1996 as a director of the Company. Seconded to dubai in 2006 and appointed as the Chief executive officer of emirates healthcare in 2007. appointed as the Company’s Chief executive officer since april 2010.

3. CI (Craig) tingle (53)Chief financial officer B.Sc. (For), B.Compt. (Hons), CA(SA)appointed in 1992 as the Financial director of the Company. after his resignation as the Financial director in 1999, he stayed on as a non-executive director until 2005 when he was appointed as the Chief Financial officer of the Company’s operations in dubai. appointed as the Company’s Chief Financial officer since September 2010.

4. Ca (ronnie) van der Merwe (49) Chief Clinical officerM.B.Ch.B., D.A. (SA), F.C.A. (SA)Joined the group in 1999 as head of the Clinical information department. Currently the Chief Clinical officer of the Company. appointed as an executive director of the Company in July 2010.

5. khs (koert) Pretorius (49)Chief Executive officer: Mediclinic southern africa B.Compt., MBL Joined the group in 1998 and appointed as a director of the Company in 2006. appointed as the Chief executive officer of Mediclinic Southern africa in 2008.

6. to (ole) wiesinger (49) Chief Executive officer: Mediclinic switzerland (hirslanden)Ph.D., Postgraduate Studies in Health Economics Joined the hirslanden group in 2004. appointed as the Chief executive officer of Mediclinic Switzerland and a director of the Company in 2008.

INDEPENDENt NoN-ExECutIvE DIrECtors 7. Dk (Desmond) smith (65)Lead Independent DirectorB.Sc., FASSA Chairman of the reinsurance group of america (rga) and Sanlam. appointed in 2008 as a director of the Company. also appointed as the lead independent director of the Company in 2010.

8. rE (robert) Leu (65)Master in Economics, Ph.D., Professor in Economicsexecutive director of the department of economics at the university of Berne in Switzerland. also serves on the board of Mediclinic Switzerland. appointed as an independent non-executive director of the Company in July 2010.

9. ZP (Zodwa) Manase (51)B.Compt. (Hons), H.Dip. (Tax), CA(SA)Chief executive officer of the audit firm, Manase & associates. appointed as a director of the Company in 2008. other directorships include total (Sa), State information technology agency and Mtn Zakhele.

10. aa (anton) raath (56)B.Comm., CA(SA)Chief executive officer of glacier, a subsidiary of Sanlam. appointed as a director of the Company in 1996.

11. wL (wynand) van der Merwe (60)M.B.Ch.B., M.Med., F.F.A. (SA), MD dean of the Faculty health Sciences of Stellenbosch university. appointed as a director of the Company in 2001.

NoN-ExECutIvE DIrECtors**12. JC (Joe) Cohen (45) B.Sc. in Economicsa managing partner of trilantic Capital partners. appointed as a director of the Company in 2008.

13. JJ (Jannie) Durand (45) B.Acc. (Hons), M.Phil. (Management Studies), CA(SA)Chief executive officer of remgro. appointed as a director of the Company in June 2012. other directorships include Capevin holdings, discovery holdings, grindrod, invenfin, Kagiso tiso holdings, rainbow Chicken and Sabido investments.

14. Mk (kabs) Makaba (59) M.B.Ch.B., Intermediate Diploma in Personnel Management and Training, Certificate in Small Business ManagementChief executive officer of Faranani health Solutions and director of phodiso holdings and ubelele holdings. appointed as a director of the Company in 2008.

15. Ma (Mamphela) ramphele (64) M.B.Ch.B., Diploma in Tropical Health and Hygiene, B.Comm., Diploma in Public Health, Ph.D.Chairperson of gold Fields. appointed as a director of the Company in 2005. other directorships include remgro and anglo american.

16. CM (Chris) van den heever (47)B.Eng. (Chem), MBAan investment manager at remgro (and previously at VenFin). appointed as a director of the Company in 2010. other directorships include one digital Media, tracker, tsb Sugar and wispeco.

* Please refer to the explanation in respect of the classification of Dr Hertzog as executive chairman on page 76 of this annual report.** Please refer to the explanation why these directors are not regarded as independent on page 77 of the Corporate Governance Report.

Page 2: our boarD aND MaNagEMENt arE CoMMIttED to DELIvErINg ...annualreport2012.mediclinic.com/downloads/Overview... · B.Compt., MBL Joined the group in 1998 and appointed as a director

MEDICLINIC INTEGRATED ANNUAL REPORT 2012 9

7. DEsMoND sMIth 8. robErt LEu

9. ZoDwa MaNasE 10. aNtoN raath 11. wyNaND vaN DEr MErwE

2. DaNIE MEINtJEs 3. CraIg tINgLE 4. roNNIE vaN DEr MErwE

5. koErt PrEtorIus 6. oLE wIEsINgEr

12. JoE CohEN

15. MaMPhELa raMPhELE 16. ChrIs vaN DEN hEEvEr14. kabs Makaba

1. EDwIN hErtZog

pe

rF

or

Ma

nC

e

hig

hl

igh

tS

Va

lu

e a

dd

ed

St

at

eM

en

t

or

ga

niS

at

ion

al

oV

er

Vie

w

Bo

ar

d o

F

dir

eC

to

rS

ou

r V

iSio

n

an

d V

al

ue

S

St

ra

te

giC

oB

Je

Ct

iVe

S

an

d in

Ve

St

Me

nt

Ca

Se

Se

Ve

n-y

ea

r

re

Vie

w

13. JaNNIE DuraND